Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-84b7d79bbc-5lx2p Total loading time: 0 Render date: 2024-07-27T18:31:04.041Z Has data issue: false hasContentIssue false

32 - Endometrial Cancer

from Section 5 - Gynecologic Oncology

Published online by Cambridge University Press:  01 February 2018

By
Katherine M. Moxley
Edited by
Lisa Keder  and
Martin E. Olsen
Lisa Keder
Affiliation:
Ohio State University
Martin E. Olsen
Affiliation:
East Tennessee State University
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Gynecologic Care , pp. 306 - 316
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

National Cancer Institute. Surveillance, Epidemiology and End Results (SEER) Stat Fact Sheets: Endometrial Cancer 2015. Washington DC: National Institutes of Health; 2015.Google Scholar
Siegel, R, Naishadham, J, Jemal, A. Cancer statistic 2012. CA Cancer J Clin 2012;62:10–29.Google Scholar
US Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), National Center for Chronic Disease Prevention and Health Promotion, Division of Nutrition, Physical Activity and Obestiy. Nutrition, Physical Activity and Obesity Data, Trends and Maps. Altanta, GA, 2015. Available at www.cdc.gov/nccdphp/DNPAO/index.html. (Accessed February 5, 2016).Google Scholar
Fader, AN, Arriba, LN, Frasure, HE et al. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol 2009;114:121–7.CrossRefGoogle ScholarPubMed
Burke, WM, Orr, J, Leitao, M et al. Endometrial cancer: a review and current management strategies: part I – an SGO Clinical Practice Endometrial Cancer Working Group study. Gynecol Oncol 2014;134:385–92.Google Scholar
Bokhman, JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15:10.Google Scholar
Boruta, DM, Gehrig, PA, Fader, AN et al. Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review. Gynecol Oncol 2009;115:142–53.CrossRefGoogle Scholar
Olawaiye, AB, Boruta, DM. Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review. Gynecol Oncol 2009;YGYNO-973066;1–7.Google ScholarPubMed
Brinton, LA, Hoover, RN. Estrogen replacement therapy and endometrial cancer risk: unresolved issues: the Endometrial Cancer Collaborative Group study. Obstet Gynecol 1993;81:265–71.Google Scholar
Fisher, B et al. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994;86(7):527–37.Google Scholar
Sherry, B, Blanck, HM, Galuska, DA, et al. Vital Signs: State-specific obesity prevalence among adults: United States, 2009. Mor Mob Weekly Rep 2010;59 (early release):1–5.Google Scholar
Soliman, PT, Wu, D, Tortolero-Luna, G et al. Association between adiponectin, insulin resistance and endometrial cancer. Cancer 2006;106(11):2376–81.Google Scholar
ACOG Practic Bulletin No. 147. American College of Obstetricians and Gynecologists. Lynch syndrome. Obstet Gynecol 2014;124(5):1042–54.Google Scholar
Smith-Bindman, R, Kerlikowski, K, Feldstein, VL et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. J Am Med Assoc 1998;280:1510–17.CrossRefGoogle ScholarPubMed
Dijkhuizen, FP, Mol BW, Brölmann HA, Heintz AP. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer 2000;89(8):1765–72.Google Scholar
Trimble, CL, Method, M, Leitao, M et al. Management of endometrial precancers. Obstet Gyencol 2012;120:1160–75.Google ScholarPubMed
Mutter, GL, Zaino, R, Baak, JP et al. Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. Int J Gynecol Pathol 2007;26:103–14.Google Scholar
Baak, JP, Mutter, GL, Robboy, S et al. The molecular genetics and morphometry based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more than the 1994 World Health Organization system. Cancer 2005;103:2304–12.Google Scholar
Trimble, CL, Kauderer, J, Zaino, R et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 2006;106:812–19.Google Scholar
Lacey, JV, Sherman, ME, Rush, BB et al. Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies. Cancer 2008;113:2073–81.CrossRefGoogle ScholarPubMed
Bansal, N, Herzog, TJ, Brunner-Brown, A et al. The utility and cost effectiveness of pre-operative computed tomography for patients with uterine malignancies. Gynecol Oncol 2008;111(2):208–12.CrossRefGoogle Scholar
Creasman, WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer 1987;60(8 Suppl):2035–41.Google Scholar
Kitchener, H, Swart, AM, Qian, Q, Amos, C, Parmar, MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised ASTEC Group study. Lancet 2009;373:125–36.Google Scholar
Benedetti Panici, P, Basile, S, Maneschi, F et al. Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008;100:1707–16.Google Scholar
Walker, JL, Piedmonte, MR, Spirtos, NM et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: a Gynecologic Oncology Group study LAP2. J Clin Oncol. 2009;27:5331–6.Google Scholar
Walker, J, Piedmonte, M, Spirtos, N, et al. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: a Gynecologic Oncology Group LAP2 study. J Clin Oncol. 2012;30:695–700.Google Scholar
Chan, JK, Gardner, AB, Taylor, K et al. Robotic versus laparoscopic versus open surgery in morbidly obese endometrial cancer patients: a comparative analysis of total charges and complication rates. Gynecol Oncol 2015;139:300–305.CrossRefGoogle ScholarPubMed
Morice, P, Leary, A, Cruetzberg, CL et al. Endometrial cancer. Lancet 2016;387:1094–1108.CrossRefGoogle ScholarPubMed
Kong, A, Johnson, N, Kitchener, HC, Lawrie, TA. Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis. J Natl Cancer Inst 2012;104:1625–34.Google Scholar
Creutzberg, CL, van Putten, WL, Koper, PC et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage 1 endometrial carcinoma: multicentre randomised trial – a PORTEC Group study, Lancet 2000;355:1404–11.Google Scholar
Keys, HM, Roberts, JA, Brunetto, VL et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004;92:744–51.CrossRefGoogle ScholarPubMed
Bendifallah, S, Canlorbe, G, Raimond, E et al. A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion. Br J Cancer 2014;110:2640–6.CrossRefGoogle ScholarPubMed
Creutzberg, CL, Nout, RA, Lybeert, ML et al. Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma: the PORTEC Group study. Int J Radiat Oncol Biol Phys 2011 Nov 15;81(4):e631–e638.CrossRefGoogle Scholar
Maggi, R, Lissoni, A, Spina, F et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer 2006;95(3):266–71.CrossRefGoogle ScholarPubMed
Nout, RA, Smit, VT, Putter, H et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomized trial. Lancet 2010;375(9717):816–23.CrossRefGoogle Scholar
Burke, WM, Orr, J, Leitao, M, et al. Endometrial cancer: a review and current management strategies: part II – an SGO Clinical Practice Endometrial Cancer Working Group study. Gynecol Oncol 2014;134:393–402.CrossRefGoogle ScholarPubMed
Meyer, LA, Bohlke, K, Powell, MA et al. Postoperative radiation therapy for endometrial cancer. American Society of Clinical Oncology, Clinical Practice Guideline, Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline. J Clin Oncol 2015;33:2908–13.Google Scholar
Landrum, LM, Moore, KN, Myers, TK et al. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? Gynecol Oncol 2009;112:337–41.CrossRefGoogle ScholarPubMed
Susumu, N, Sagae, S, Udagawa, Y et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol 2008;108(1):226–33.CrossRefGoogle ScholarPubMed
McMeekin, DS, Filiaci, VL, Aghajanian, C et al. A randomized phase III trial of pelvic radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy (VCB/C) in patients with high risk (HR), early stage endometrial cancer (EC): a Gynecologic Oncology Group trial. Gynecol Oncol 2014;134:438 (abstract).CrossRefGoogle Scholar
Lambrou, NC et al. Optimal surgical cytoreduction in patients with stage III and stage IV endometrial carcinoma: a study of morbidity and survival. Gynecol Oncol 2004;93(3):653–8.CrossRefGoogle ScholarPubMed
Bristow, RE et al. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival. Gynecol Oncol 2000;78(2):85–91.CrossRefGoogle ScholarPubMed
National Comprehensive Cancer Network. Uterine neoplasms, www.nccn.org/professionals/physician_gls/pdf/uterine.pdf. Accessed March 1, 2016.Google Scholar
Randall, ME, Filiaci, VL, Muss, H et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2006;24:36–44.CrossRefGoogle ScholarPubMed
Fleming, GF, Brunetto, VL, Cella, D et al. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2004;22(11):2159–66.CrossRefGoogle ScholarPubMed
Miller, D, Filiaci, V, Fleming, G, Mannel, R et al. Randomized phase III noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2012;125:771 (abstract).Google Scholar
Fiorca, JV, Brunetto, VL, Hanjani, P et al. Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004;92:10–14.Google Scholar
Fleming, GF. Systemic chemotherapy for uterine carcinoma: metastatic and adjuvant. J Clin Oncol 2007;25:2983–90.CrossRefGoogle ScholarPubMed
Khoury-Collado, F, Einstein, MH, Bochner, BH et al. Pelvic exenteration with curative intent for recurrent uterine malignancies. Gynecol Oncol 2012;124(1):42–7.CrossRefGoogle ScholarPubMed
Bradford, LS, Rauh-Hain, JA, Schorge, J, Birrer, MJ, Dizon, DS. Advances in the management of recurrent endometrial cancer. Am J Clin Oncol 2015;38:206–12.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×